Bure Equity AB (publ) ("Bure") has sold 7,800,000 shares in Mycronic AB (publ) ("Mycronic") to Swedish and International investors.
Following the placing, Bure owns 29,317,163 shares in Mycronic corresponding to 29.9 per cent of the capital and votes.
Bure Equity AB (publ)
For additional information, please contact:
Henrik Blomquist, CEO
Tel. +46 8 – 614 00 20
The information contained herein is subject to the disclosure requirements of Bure Equity AB under the Swedish Securities Market Act. The information has been publicly communicated on 20 November 2015, 08:30 CET.